COMMUNIQUÉS West-GlobeNewswire

RAMSAY SANTE :repricing launch 20 01 2025
20/01/2025
PRESS RELEASE Paris, 20 January 2025 Ramsay Santé launches the repricing of its €1,025m TLB4 due 2031 On 13 August 2024, Ramsay Santé closed an Amend & Extend of its €1,650m Senior Debt facilities, including a €1, [...]
RAMSAY SANTE : lancement repricing 20 janvier 2025
20/01/2025
COMMUNIQUÉ DE PRESSE Paris, le 20 janvier 2025 Ramsay Santé lance le repricing de sa tranche TLB 4 de €1,025m due en 2031 Le 13 août 2024, Ramsay Santé a finalisé le process d’« Amend & Extend » de son contrat de [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
20/01/2025
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 15 janvier 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering
20/01/2025
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “ Company ”, “ Kane ” or “ Kane [...]
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
20/01/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Jan. 20, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
20/01/2025
SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Segra International and GreenBe Pharma Forge a Partnership to Streamline Access to Elite Cannabis Genetics Across Europe
20/01/2025
Award-Winning Tissue Culture Clones Now Locally Available, Simplifying European Cultivators’ Supply Chain VANCOUVER, British Columbia, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Segra International (“Segra”), a globally [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
20/01/2025
COPENHAGEN, Denmark, January 20, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on January 9, 2025, under which the Company will repurchase shares for an amount [...]
Lifecore Biomedical Announces Special Stockholder Meeting
17/01/2025
Company Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred Stock Terms CHASKA, Minn., Jan. 17, 2025 (GLOBE [...]
XORTX Announces Change of Auditor
17/01/2025
CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
17/01/2025
SAN CARLOS, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025
NOVATO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025
WALTHAM, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
17/01/2025
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the [...]
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)
17/01/2025
WATERTOWN, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
Scorpius Holdings Cancels Planned Reverse Stock Split
17/01/2025
DURHAM, N.C., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced [...]
Cannabis Means Business (CMB), New York Global Edition, Opens Registration
17/01/2025
Experience the Premier Trade Show & Conference, June 4-5, For Cannabis Industry Professionals NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- via IBN – Cannabis Means Business (CMB), the premier business to business [...]
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
17/01/2025
LAKEWOOD, Colo., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2025 at approximately 8:00 A.M. Eastern [...]
GUERBET : Bilan semestriel du contrat de liquidité
17/01/2025
Bilan semestriel du contrat de liquidité Villepinte, le 17 janvier 2025 Au titre du contrat de liquidité confié par la société GUERBET à BNP Paribas, en date de dénouement du 31 décembre 2024, les moyens suivants [...]

Pages